Opeyemi. O. Deji-Oloruntoba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Opeyemi. O. Deji-Oloruntoba has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Miran Jang
Department of Food Technology and Nutrition, Inje University, Gimhae 50834, Republic of Korea
4 shared publications - Simeon Okechukwu Ajakwe
Department of Smart Computing, Kyungdong University
3 shared publications - Taiwo. O. Elufioye
Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan 200005, Nigeria
2 shared publications - Adefarati Oloruntoba
Department of Chemical and Petroleum Engineering, University of Calgary, Calgary, AB T2N 1N4, Canada
1 shared publication - Ariful Islam Mozumder
Institute of Digital Anti-Aging Healthcare, Inje University, Gimhae 50834, Republic of Korea
1 shared publication - Ayun Seol
Department of Biomaterials Science (BK21 FOUR Program), Life and Industry Convergence Research Institute, College of Natural Resources and Life Science, Pusan National University, Miryang 50463, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by MDPI AG in Nutraceuticals
- Vol. 6  (3) , 52
Computational Toxicology for Nutraceutical Safety Assessment: Bridging Rapid Innovation with Reliable Risk Evaluation
The rapid expansion of the global nutraceutical industry has heightened the urgency for rigorous yet efficient safety assessment of food-derived bioactives. Conventional toxicological methods, while indispensable, are often costly, time-consuming, and insufficient to keep pace with the rapid product innovation in this sector. In this context, in silico models for predicting Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET), alongside broader computational toxicology tools, are increasingly recognized as scalable and cost-effective strategies for early-stage safety evaluation of nutraceuticals. Techniques such as quantitative structure–activity relationship (QSAR) modeling, molecular docking, and physiologically based pharmacokinetic (PBPK) simulation enable early prioritization of candidate compounds, forecasting of potential enzyme- or receptor-mediated interactions, and prediction of bioactive metabolite profiles, prior to costly experimental or clinical evaluation. Yet, their application in the nutraceutical domain presents unique challenges. Food matrices are chemically complex, bioactive data remain sparse and unevenly curated, and long-term, low-dose effects are difficult to capture with existing computational frameworks. These limitations constrain predictive accuracy and raise questions about general applicability across diverse classes of compounds. Therefore, this review critically examines both the opportunities and limitations of computational safety assessment for nutraceuticals. It synthesizes representative case studies, evaluates current methodological limitations, and discusses the evolving regulatory landscape alongside emerging integrative frameworks such as New Approach Methodologies (NAMs) that may guide the future of nutraceutical safety assessment.
- 5 August 2026
- Published by MDPI AG in Nutraceuticals
- Vol. 6  (3) , 52
Open AccessComputational Toxicology for Nutraceutical Safety Assessment: Bridging Rapid Innovation with Reliable Risk Evaluation
The rapid expansion of the global nutraceutical industry has heightened the urgency for rigorous yet efficient safety assessment of food-derived bioactives. Conventional toxicological methods, while indispensable, are often costly, time-consuming, and insufficient to keep pace with the rapid product innovation in this sector. In this context, in silico models for predicting Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET), alongside broader computational toxicology tools, are increasingly recognized as scalable and cost-effective strategies for early-stage safety evaluation of nutraceuticals. Techniques such as quantitative structure–activity relationship (QSAR) modeling, molecular docking, and physiologically based pharmacokinetic (PBPK) simulation enable early prioritization of candidate compounds, forecasting of potential enzyme- or receptor-mediated interactions, and prediction of bioactive metabolite profiles, prior to costly experimental or clinical evaluation. Yet, their application in the nutraceutical domain presents unique challenges. Food matrices are chemically complex, bioactive data remain sparse and unevenly curated, and long-term, low-dose effects are difficult to capture with existing computational frameworks. These limitations constrain predictive accuracy and raise questions about general applicability across diverse classes of compounds. Therefore, this review critically examines both the opportunities and limitations of computational safety assessment for nutraceuticals. It synthesizes representative case studies, evaluates current methodological limitations, and discusses the evolving regulatory landscape alongside emerging integrative frameworks such as New Approach Methodologies (NAMs) that may guide the future of nutraceutical safety assessment.
- Open Access
- 1 May 2026
- Published by MDPI AG in Sustainability
- Vol. 18  (9) , 4436
Climate Change Anxiety: Drivers, Impact, and Mitigation Interventions—A Multi-Country Survey
Climate change is increasingly recognized as a source of psychological distress, yet the prevalence, predictors, and behavioral implications of climate anxiety remain unevenly understood. This study examines climate anxiety, its key drivers, and associated behavioral responses in a multi-country sample of adults. A cross-sectional online survey was conducted across 21 countries using the Climate Change Anxiety Scale (CCAS), alongside measures of awareness, coping strategies, social support, and food-related behaviors, including food waste reduction, increased plant-based food consumption, and home or community gardening. Analyses included descriptive statistics, exploratory factor analysis (EFA), and multivariable regression. Given the uneven country-level representation, results are reported as pooled patterns with a few exploratory cross-country comparisons. Climate anxiety was widely reported, with over 60% of participants indicating that climate challenges were emotionally overwhelming. Regression analyses showed that climate awareness and frequency of climate-related thinking were positively associated with higher anxiety, although the effect sizes were small and explanatory power was limited (R2 = 0.055). EFA identified two related dimensions: cognitive concern about future impacts and affective distress. Climate anxiety across countries showed modest variation (2.44–3.23) and no statistically significant differences, despite variation in awareness. A gap between concern and climate action was evident: only 39.1% reported environmentally motivated dietary changes. Cost, limited availability, and lack of information were the main barriers to climate action, and only 24.4% reported frequent social support. These findings indicate that climate anxiety is shaped by both psychological and structural factors, and that reducing it requires not only increasing awareness but also enabling conditions that support meaningful climate action.
- 1 May 2026
- Published by MDPI AG in Sustainability
- Vol. 18  (9) , 4436
Open AccessClimate Change Anxiety: Drivers, Impact, and Mitigation Interventions—A Multi-Country Survey
Climate change is increasingly recognized as a source of psychological distress, yet the prevalence, predictors, and behavioral implications of climate anxiety remain unevenly understood. This study examines climate anxiety, its key drivers, and associated behavioral responses in a multi-country sample of adults. A cross-sectional online survey was conducted across 21 countries using the Climate Change Anxiety Scale (CCAS), alongside measures of awareness, coping strategies, social support, and food-related behaviors, including food waste reduction, increased plant-based food consumption, and home or community gardening. Analyses included descriptive statistics, exploratory factor analysis (EFA), and multivariable regression. Given the uneven country-level representation, results are reported as pooled patterns with a few exploratory cross-country comparisons. Climate anxiety was widely reported, with over 60% of participants indicating that climate challenges were emotionally overwhelming. Regression analyses showed that climate awareness and frequency of climate-related thinking were positively associated with higher anxiety, although the effect sizes were small and explanatory power was limited (R2 = 0.055). EFA identified two related dimensions: cognitive concern about future impacts and affective distress. Climate anxiety across countries showed modest variation (2.44–3.23) and no statistically significant differences, despite variation in awareness. A gap between concern and climate action was evident: only 39.1% reported environmentally motivated dietary changes. Cost, limited availability, and lack of information were the main barriers to climate action, and only 24.4% reported frequent social support. These findings indicate that climate anxiety is shaped by both psychological and structural factors, and that reducing it requires not only increasing awareness but also enabling conditions that support meaningful climate action.
- Open Access
- 8 September 2025
- Published by MDPI AG in Metabolites
- Vol. 15  (9) , 594
Phenolic-Rich Indian Almond (Terminalia catappa Linn) Leaf Extract Ameliorates Lipid Metabolism and Inflammation in High-Fat Diet (HFD)-Induced Obese Mice
Background: Obesity is a global health issue closely associated with dysregulated lipid metabolism and chronic inflammation. Effective strategies targeting both lipogenesis and inflammation are essential for managing obesity and its related metabolic disorders. Methods: This study evaluated the effects of Terminalia catappa Linn. leaf extract (TCE) on lipogenic and lipolytic pathways in high-fat diet (HFD)-induced obese mice. UPLC-QTOF-MS analysis was conducted to identify and quantify the major phenolic compounds in TCE. Mice were administered low and high doses of TCE, and various metabolic parameters, including lipid profiles, liver function markers, adipokine levels, and gene/protein expressions related to lipid metabolism and inflammation, were assessed. Results: UPLC-QTOF-MS analysis identified four major phenolic compounds in TCE—gallic acid, orientin, vitexin, and ellagic acid—with respective contents of 112.5, 163.3, 184.7, and 295.7 mg/g extract. TCE administration significantly reduced liver and adipose tissue weights, along with hepatic and adipose lipid accumulation. Both low and high doses of TCE markedly lowered serum lipid levels. Liver function was improved, as indicated by reduced levels of AST, ALT, and ALP, while BUN levels remained unchanged. On the molecular level, TCE downregulated adipogenic and lipogenic genes (PPARγ, PPARα, C/EBPα, aP2) and upregulated metabolic regulators, including leptin, adiponectin, p-HSL/HSL, and p-perilipin/perilipin, without affecting ATGL expression. TCE also suppressed pro-inflammatory cytokines such as IL-6, IL-1β, TNF-α, and TGFβ-1. Conclusions: These findings highlight the therapeutic potential of TCE in managing obesity by inhibiting lipogenesis, enhancing lipolysis, and reducing inflammation.
- 8 September 2025
- Published by MDPI AG in Metabolites
- Vol. 15  (9) , 594
Open AccessPhenolic-Rich Indian Almond (Terminalia catappa Linn) Leaf Extract Ameliorates Lipid Metabolism and Inflammation in High-Fat Diet (HFD)-Induced Obese Mice
Background: Obesity is a global health issue closely associated with dysregulated lipid metabolism and chronic inflammation. Effective strategies targeting both lipogenesis and inflammation are essential for managing obesity and its related metabolic disorders. Methods: This study evaluated the effects of Terminalia catappa Linn. leaf extract (TCE) on lipogenic and lipolytic pathways in high-fat diet (HFD)-induced obese mice. UPLC-QTOF-MS analysis was conducted to identify and quantify the major phenolic compounds in TCE. Mice were administered low and high doses of TCE, and various metabolic parameters, including lipid profiles, liver function markers, adipokine levels, and gene/protein expressions related to lipid metabolism and inflammation, were assessed. Results: UPLC-QTOF-MS analysis identified four major phenolic compounds in TCE—gallic acid, orientin, vitexin, and ellagic acid—with respective contents of 112.5, 163.3, 184.7, and 295.7 mg/g extract. TCE administration significantly reduced liver and adipose tissue weights, along with hepatic and adipose lipid accumulation. Both low and high doses of TCE markedly lowered serum lipid levels. Liver function was improved, as indicated by reduced levels of AST, ALT, and ALP, while BUN levels remained unchanged. On the molecular level, TCE downregulated adipogenic and lipogenic genes (PPARγ, PPARα, C/EBPα, aP2) and upregulated metabolic regulators, including leptin, adiponectin, p-HSL/HSL, and p-perilipin/perilipin, without affecting ATGL expression. TCE also suppressed pro-inflammatory cytokines such as IL-6, IL-1β, TNF-α, and TGFβ-1. Conclusions: These findings highlight the therapeutic potential of TCE in managing obesity by inhibiting lipogenesis, enhancing lipolysis, and reducing inflammation.
- Open Access
- 10 July 2025
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 5  (3) , 30
Hyperuricemia and Insulin Resistance: Interplay and Potential for Targeted Therapies
Hyperuricemia, defined as elevated serum uric acid (SUA) levels (>6.8 mg/dL), is traditionally linked to gout and nephrolithiasis but is increasingly implicated in insulin resistance (IR) and type 2 diabetes mellitus (T2DM). Epidemiological studies, such as NHANES, suggest hyperuricemia increases the risk of T2DM by 1.6 to 2.5 times. Mechanistically, uric acid promotes IR via oxidative stress, chronic inflammation, endothelial dysfunction, and adipocyte dysregulation. Despite growing evidence, significant gaps remain in understanding these pathways, with existing studies often limited by observational designs and short intervention durations. A bibliographic analysis of studies from 2004–2024 using Web of Science and VOSviewer highlights a growing focus on hyperuricemia’s interplay with inflammation, oxidative stress, and metabolic disorders. However, inconsistencies in therapeutic outcomes and limited exploration of causality underscore the need for further research. We also explored the importance of gender stratification and the limitations of the binary model for the relationship between hyperuricemia and insulin resistance. This review emphasizes the importance of addressing these gaps to optimize hyperuricemia management as a potential strategy for diabetes prevention and metabolic health improvement.
- 10 July 2025
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 5  (3) , 30
Open AccessHyperuricemia and Insulin Resistance: Interplay and Potential for Targeted Therapies
Hyperuricemia, defined as elevated serum uric acid (SUA) levels (>6.8 mg/dL), is traditionally linked to gout and nephrolithiasis but is increasingly implicated in insulin resistance (IR) and type 2 diabetes mellitus (T2DM). Epidemiological studies, such as NHANES, suggest hyperuricemia increases the risk of T2DM by 1.6 to 2.5 times. Mechanistically, uric acid promotes IR via oxidative stress, chronic inflammation, endothelial dysfunction, and adipocyte dysregulation. Despite growing evidence, significant gaps remain in understanding these pathways, with existing studies often limited by observational designs and short intervention durations. A bibliographic analysis of studies from 2004–2024 using Web of Science and VOSviewer highlights a growing focus on hyperuricemia’s interplay with inflammation, oxidative stress, and metabolic disorders. However, inconsistencies in therapeutic outcomes and limited exploration of causality underscore the need for further research. We also explored the importance of gender stratification and the limitations of the binary model for the relationship between hyperuricemia and insulin resistance. This review emphasizes the importance of addressing these gaps to optimize hyperuricemia management as a potential strategy for diabetes prevention and metabolic health improvement.
- Open Access
Limosilactobacillus fermentum MG4244 Protects Against Metabolic and Inflammatory Stress in Caenorhabditis elegans
In this study, we investigated the effects of MG4244 on intestinal permeability, oxidative stress, and lipid accumulation in Caenorhabditis elegans with metabolic inflammation induced by Pseudomonas aeruginosa (PA) and a high-glucose diet (HGD). The worms infected with PA exhibited increased intestinal permeability and reactive oxygen species (ROS) production, which were improved upon MG4244 treatment. Also, MG4244 inhibited lipid and ROS accumulation induced by an HGD. In addition, MG4244-treated worms showed extended lifespans under various conditions. To elucidate the mechanism of the MG4244 effects, we conducted further investigation using mutant strains with knockdown of genes associated with the AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) pathways. The results demonstrated that the MG4244 effect on lipid metabolism was primarily mediated through the AMPK signaling pathway. Furthermore, MG4244 enhanced pathogen resistance by MAPK signaling pathways, mitigating stress responses, and maintaining intestinal integrity. In further studies, combined treatment with PA and an HGD significantly increased intestinal permeability, lipid, and ROS levels, confirming their negative synergistic effects. However, MG4244 under PA and HGD co-treatment conditions effectively mitigated these health disruptions, suggesting a protective role of MG4244. This study provides an in vivo platform using C. elegans to evaluate probiotic efficacy related to the intestinal environment. Also, our results highlight the therapeutic potential of MG4244 in improving resilience to metabolic inflammation through gut-targeted mechanisms.
Open AccessLimosilactobacillus fermentum MG4244 Protects Against Metabolic and Inflammatory Stress in Caenorhabditis elegans
In this study, we investigated the effects of MG4244 on intestinal permeability, oxidative stress, and lipid accumulation in Caenorhabditis elegans with metabolic inflammation induced by Pseudomonas aeruginosa (PA) and a high-glucose diet (HGD). The worms infected with PA exhibited increased intestinal permeability and reactive oxygen species (ROS) production, which were improved upon MG4244 treatment. Also, MG4244 inhibited lipid and ROS accumulation induced by an HGD. In addition, MG4244-treated worms showed extended lifespans under various conditions. To elucidate the mechanism of the MG4244 effects, we conducted further investigation using mutant strains with knockdown of genes associated with the AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) pathways. The results demonstrated that the MG4244 effect on lipid metabolism was primarily mediated through the AMPK signaling pathway. Furthermore, MG4244 enhanced pathogen resistance by MAPK signaling pathways, mitigating stress responses, and maintaining intestinal integrity. In further studies, combined treatment with PA and an HGD significantly increased intestinal permeability, lipid, and ROS levels, confirming their negative synergistic effects. However, MG4244 under PA and HGD co-treatment conditions effectively mitigated these health disruptions, suggesting a protective role of MG4244. This study provides an in vivo platform using C. elegans to evaluate probiotic efficacy related to the intestinal environment. Also, our results highlight the therapeutic potential of MG4244 in improving resilience to metabolic inflammation through gut-targeted mechanisms.
- Open Access
- 2 May 2025
- Published by MDPI AG in Applied Biosciences
- Vol. 4  (2) , 23
Can Caenorhabditis elegans Serve as a Reliable Model for Drug and Nutraceutical Discovery?
Experimental research demands the selection of appropriate models to align with study objectives and conditions. Traditional experimental models, such as in vivo animal studies and in vitro systems like organoids, present nutraceutical and pharmaceutical research limitations such as high cost, ethical concerns, long lifespan, and difficult genetic manipulation. Caenorhabditis elegans has proved to be a valuable model as a result of its genetic and physiological similarities to higher organisms, fully sequenced genome, short life cycle, and transparency. These features enable high-throughput screening, molecular pathway analysis, and lifespan and healthspan assays. C. elegans has significantly advanced the discovery of bioactive molecules with therapeutic potential, shedding light on aging, neurodegeneration, metabolic disorders, and immune responses. Its utility in pharmacokinetics and validation of nutraceuticals underscores its role in longevity and metabolic health research. Additionally, its conserved stress response, apoptosis, and pathogen recognition pathways facilitate the study of pharmacological interventions for inflammation, oxidative stress, and infections. This study evaluates the applicability of C. elegans as a model for in vivo screening, analyses its role in drug efficacy testing, and discusses relevant advancements, associated difficulties, and what to expect of C. elegans in research.
- 2 May 2025
- Published by MDPI AG in Applied Biosciences
- Vol. 4  (2) , 23
Open AccessCan Caenorhabditis elegans Serve as a Reliable Model for Drug and Nutraceutical Discovery?
Experimental research demands the selection of appropriate models to align with study objectives and conditions. Traditional experimental models, such as in vivo animal studies and in vitro systems like organoids, present nutraceutical and pharmaceutical research limitations such as high cost, ethical concerns, long lifespan, and difficult genetic manipulation. Caenorhabditis elegans has proved to be a valuable model as a result of its genetic and physiological similarities to higher organisms, fully sequenced genome, short life cycle, and transparency. These features enable high-throughput screening, molecular pathway analysis, and lifespan and healthspan assays. C. elegans has significantly advanced the discovery of bioactive molecules with therapeutic potential, shedding light on aging, neurodegeneration, metabolic disorders, and immune responses. Its utility in pharmacokinetics and validation of nutraceuticals underscores its role in longevity and metabolic health research. Additionally, its conserved stress response, apoptosis, and pathogen recognition pathways facilitate the study of pharmacological interventions for inflammation, oxidative stress, and infections. This study evaluates the applicability of C. elegans as a model for in vivo screening, analyses its role in drug efficacy testing, and discusses relevant advancements, associated difficulties, and what to expect of C. elegans in research.
- Open Access
- 1 August 2024
- Published by MDPI AG in BioMedInformatics
- Vol. 4  (3) , 1807-1821
ELIPF: Explicit Learning Framework for Pre-Emptive Forecasting, Early Detection and Curtailment of Idiopathic Pulmonary Fibrosis Disease
(1) Background: Among lung diseases, idiopathic pulmonary fibrosis (IPF) appears to be the most common type and causes scarring (fibrosis) of the lungs. IPF disease patients are recommended to undergo lung transplants, or they may witness progressive and irreversible lung damage that will subsequently lead to death. In cases of irreversible damage, it becomes important to predict the patient’s mortality status. Traditional healthcare does not provide sophisticated tools for such predictions. Still, because artificial intelligence has effectively shown its capability to manage crucial healthcare situations, it is possible to predict patients’ mortality using machine learning techniques. (2) Methods: This research proposed a soft voting ensemble model applied to the top 30 best-fit clinical features to predict mortality risk for patients with idiopathic pulmonary fibrosis. Five machine learning algorithms were used for it, namely random forest (RF), support vector machine (SVM), gradient boosting machine (GBM), XGboost (XGB), and multi-layer perceptron (MLP). (3) Results: A soft voting ensemble method applied with the combined results of the classifiers showed an accuracy of 79.58%, sensitivity of 86%, F1-score of 84%, prediction error of 0.19, and responsiveness of 0.47. (4) Conclusions: Our proposed model will be helpful for physicians to make the right decision and keep track of the disease, thus reducing the mortality risk, improving the overall health condition of patients, and managing patient stratification.
- 1 August 2024
- Published by MDPI AG in BioMedInformatics
- Vol. 4  (3) , 1807-1821
Open AccessELIPF: Explicit Learning Framework for Pre-Emptive Forecasting, Early Detection and Curtailment of Idiopathic Pulmonary Fibrosis Disease
(1) Background: Among lung diseases, idiopathic pulmonary fibrosis (IPF) appears to be the most common type and causes scarring (fibrosis) of the lungs. IPF disease patients are recommended to undergo lung transplants, or they may witness progressive and irreversible lung damage that will subsequently lead to death. In cases of irreversible damage, it becomes important to predict the patient’s mortality status. Traditional healthcare does not provide sophisticated tools for such predictions. Still, because artificial intelligence has effectively shown its capability to manage crucial healthcare situations, it is possible to predict patients’ mortality using machine learning techniques. (2) Methods: This research proposed a soft voting ensemble model applied to the top 30 best-fit clinical features to predict mortality risk for patients with idiopathic pulmonary fibrosis. Five machine learning algorithms were used for it, namely random forest (RF), support vector machine (SVM), gradient boosting machine (GBM), XGboost (XGB), and multi-layer perceptron (MLP). (3) Results: A soft voting ensemble method applied with the combined results of the classifiers showed an accuracy of 79.58%, sensitivity of 86%, F1-score of 84%, prediction error of 0.19, and responsiveness of 0.47. (4) Conclusions: Our proposed model will be helpful for physicians to make the right decision and keep track of the disease, thus reducing the mortality risk, improving the overall health condition of patients, and managing patient stratification.
- 17 January 2024
- Published by IGI Global Scientific Publishing
- p. 217-245
Machine Learning in UAV-Assisted Smart Farming
Over the years, economic loss in the agricultural sector has been attributed to the late detection of varying plant diseases due to incongruent detection technologies. With the advent of disruptive technologies and their deployment, such as incorporating artificial intelligence (AI) models into unmanned autonomous vehicles for real-time monitoring, the curtailment of losses and inadvertent waste of agricultural produce can be significantly addressed. This study examines the role of deploying AI models in improving the early and accurate detection of crop lesions for prompt, intuitive, and decisive action to forestall recurrence and guarantee a return on investment to farmers. Furthermore, the chapter established scientific basis for the acceleration of crop yields through allied mechano-biosynthesis in a quest to cushion the effect of the contemporary global food crisis. Connected intelligence in smart farming can be achieved through convergence technology for cost effective agro-allied production by improving the limitations of UAVs and AI-models.
- 17 January 2024
- Published by IGI Global Scientific Publishing
- p. 217-245
Machine Learning in UAV-Assisted Smart Farming
Over the years, economic loss in the agricultural sector has been attributed to the late detection of varying plant diseases due to incongruent detection technologies. With the advent of disruptive technologies and their deployment, such as incorporating artificial intelligence (AI) models into unmanned autonomous vehicles for real-time monitoring, the curtailment of losses and inadvertent waste of agricultural produce can be significantly addressed. This study examines the role of deploying AI models in improving the early and accurate detection of crop lesions for prompt, intuitive, and decisive action to forestall recurrence and guarantee a return on investment to farmers. Furthermore, the chapter established scientific basis for the acceleration of crop yields through allied mechano-biosynthesis in a quest to cushion the effect of the contemporary global food crisis. Connected intelligence in smart farming can be achieved through convergence technology for cost effective agro-allied production by improving the limitations of UAVs and AI-models.